Proximagen Limited
Babraham Research Campus
Minerva Building 250
Cambridge
CB22 3AT
United Kingdom
Tel: +44-1223-497300
Website: http://www.proximagen.com/
7 articles about Proximagen Limited
-
Proximagen Enhances Medicinal Chemists' Toolkit With Flare for Structure-Based Design
12/12/2017
Cresset is pleased to announce that Proximagen, a drug discovery and development company, has licensed Flare.
-
MRC Technology And Proximagen Group plc. Collaborate To Develop Novel Therapeutics For Inflammatory And Autoimmune Disease
10/13/2014
-
Upsher-Smith Laboratories Completes Acquisition of Proximagen Group plc.
8/14/2012
-
Upsher-Smith Laboratories Takes Over Proximagen Group plc. for $553 Million
6/13/2012
-
Lundbeck Inc. to Make $16 Million Investment in Proximagen Group plc.
9/29/2011
-
Proximagen Group plc. Release: Interim Results for the Six Months Ended 31 May 2011
7/25/2011
-
Proximagen Group plc. Unaudited Preliminary Statement of Annual Results for the Year Ended 30 November 2010
3/23/2011